SGTs | Freq. | M: F | Age range (yrs) | Mean age (yrs) (±SD) | Percentage of total tumours | Percentage in group (benign or malignant) |
BENIGN | ||||||
Pleomorphic adenoma | 27 | 1.1:1 | 15 - 75 | 36.30 (±16.84} | 26.2 | 77.1 |
Haemangioma | 3 | 2:1 | 13 - 25 | 17.00 (±6.93) | 2.9 | 8.6 |
Monomorphic adenoma | 2 | 0:2 | 25 - 38 | 30.50 (±10.61) | 1.9 | 5.7 |
Neurofibroma | 2 | 0:2 | 20 - 22 | 21.00 (±1.41) | 1.9 | 5.7 |
Lymphangioma | 1 | 0:1 | 1 | 0.90 | 1.0 | 2.9 |
Total benign | 35 | 1:1.2 | 1 - 75 | 32.43 (±17.12) | 34.0 | 100 |
MALIGNANT | ||||||
Squamous cell carcinoma | 32 | 1.3:1 | 20 - 71 | 49.38 (±16.01) | 31.1 | 47.1 |
Adenoid cystic carcinoma | 16 | 1.3:1 | 23 - 75 | 49.19 (±15.68) | 15.5 | 23.5 |
Mucoepidermoid carcinoma | 6 | 1:1 | 13 - 53 | 30.83 (±16.73) | 5.8 | 8.8 |
Sarcoma | 5 | 1.5:1 | 25 - 45 | 33.20 (±8.87) | 4.9 | 7.4 |
Lymphoma | 3 | 2:1 | 35 - 58 | 47.67 (±11.68) | 2.9 | 4.4 |
Carcinoma ex-pleomorphic adenoma | 2 | 2:0 | 55 - 60 | 57.50 (±3.54) | 1.9 | 2.9 |
Acinic cell carcinoma | 1 | 0:1 | 51 | 51.00 | 1.0 | 1.5 |
Adenocarcinoma | 1 | 0:1 | 24 | 24.00 | 1.0 | 1.5 |
Salivary ductal carcinoma | 1 | 1:0 | 35 | 35.00 | 1.0 | 1.5 |
Basal cell adenocarcinoma | 1 | 1:0 | 70 | 70.00 | 1.0 | 1.5 |
Total malignant | 68 | 1.4:1 | 13 - 75 | 46.41 (±16.31) | 66.0 | 100 |
TOTAL | 103 | 1.2:1 | 1 - 75 | 41.66 (±17.80) | 100.0 |
|